Latvia vs New Zealand: Proportion of the target population who received the final dose of
Latvia
51.0%
in 2024
New Zealand
52.0%
in 2024
Latvia rank
73rd
New Zealand rank
71st
Proportion of the target population who received the final dose of over time
- Latvia
- New Zealand
How they compare
New Zealand currently reports 52.0% against 51.0% in Latvia, a difference of 1.0%.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was Latvia ahead.
Latvia ranks 73rd and New Zealand ranks 71st of 107 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 42.1% | 56.9% | 14.8% | New Zealand |
| 2020s | 43.6% | 57.2% | 13.6% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Latvia or New Zealand?
- New Zealand, at 52.0% against 51.0% in Latvia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Latvia and New Zealand?
- 1.0%, with New Zealand ahead.
- How many years of comparable data are there for Latvia and New Zealand?
- 14 years are reported by both, from 2011 to 2024.
- How do Latvia and New Zealand rank globally for proportion of the target population who received the final dose of?
- Latvia ranks 73rd and New Zealand ranks 71st of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.